Nemysis Limited, through its subsidiary Enteralia Bioscience SRL, has acquired TFarma SRL, a leading Italian distributor specializing in women’s health and gastroenterology. TFarma’s experienced sales team and strong network provide a robust platform for Enteralia to expand in Italy, a major European healthcare market. This acquisition supports Nemysis’s strategy to deliver innovative solutions, including its IHAT nano-particulate oral iron therapy. Combining TFarma’s commercial capabilities with Enteralia’s product pipeline enhances their presence in women’s health and gastroenterology. The move marks a key step in Nemysis’s evolution into a fully integrated biopharmaceutical and healthcare organization.
#NemysisLimited #EnteraliaBioscience #TFarma #HealthcareInnovation #WomensHealth #Gastroenterology #Pharmaceuticals #IHATTherapy #Biopharma #HealthcareItaly #MarketExpansion #NanoTherapy #NutritionalSolutions #MedicalInnovation
留言